UBS AM’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History

UBS AM’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-53,554	Closed	-$810K	–	2807
2022 Q3	$810K	Buy	53,554 +2,310	+5%	+$35K	﹤0.01%	2094
2022 Q2	$384K	Sell	51,244 -3,549	-6%	-$26.6K	﹤0.01%	2391
2022 Q1	$499K	Hold	54,793	–	–	﹤0.01%	2463
2021 Q4	$385K	Hold	54,793	–	–	﹤0.01%	2625
2021 Q3	$625K	Buy	54,793 +67	+0.1%	+$764	﹤0.01%	2408
2021 Q2	$876K	Buy	54,726 +12,650	+30%	+$203K	﹤0.01%	2275
2021 Q1	$752K	Hold	42,076	–	–	﹤0.01%	2216
2020 Q4	$568K	Hold	42,076	–	–	﹤0.01%	2255
2020 Q3	$495K	Sell	42,076 -1,168	-3%	-$13.7K	﹤0.01%	2150
2020 Q2	$638K	Buy	43,244 +1,522	+4%	+$22.5K	﹤0.01%	2013
2020 Q1	$563K	Buy	41,722 +3,586	+9%	+$48.4K	﹤0.01%	1932
2019 Q4	$922K	Buy	38,136 +7,575	+25%	+$183K	﹤0.01%	1954
2019 Q3	$587K	Buy	30,561 +3,699	+14%	+$71.1K	﹤0.01%	2204
2019 Q2	$794K	Sell	26,862 -4,282	-14%	-$127K	﹤0.01%	2004
2019 Q1	$1.48M	Sell	31,144 -72,404	-70%	-$3.44M	﹤0.01%	1663
2018 Q4	$3.74M	Sell	103,548 -1,612	-2%	-$58.2K	﹤0.01%	1191
2018 Q3	$6.47M	Buy	105,160 +5,536	+6%	+$341K	﹤0.01%	1055
2018 Q2	$6.73M	Sell	99,624 -9,818	-9%	-$663K	0.01%	1055
2018 Q1	$5.94M	Sell	109,442 -5,371	-5%	-$291K	﹤0.01%	1092
2017 Q4	$6.86M	Buy	114,813 +74,130	+182%	+$4.43M	0.01%	1011
2017 Q3	$1.98M	Buy	40,683 +23,522	+137%	+$1.14M	﹤0.01%	1412
2017 Q2	$902K	Buy	17,161 +4,731	+38%	+$249K	﹤0.01%	1702
2017 Q1	$564K	Buy	12,430 +6,130	+97%	+$278K	﹤0.01%	1823
2016 Q4	$238K	Sell	6,300 -5,400	-46%	-$204K	﹤0.01%	2034
2016 Q3	$442K	Buy	+11,700	New	+$442K	﹤0.01%	2047
2016 Q1	–	Sell	-9,200	Closed	-$224K	–	2680
2015 Q4	$224K	Sell	9,200 -2,500	-21%	-$60.9K	﹤0.01%	2473
2015 Q3	$208K	Sell	11,700 -1,600	-12%	-$28.4K	﹤0.01%	2476
2015 Q2	$235K	Buy	13,300 +5,200	+64%	+$91.9K	﹤0.01%	2511
2015 Q1	$254K	Buy	+8,100	New	+$254K	﹤0.01%	2367